Crohn’s disease

ADALIMUMAB AND INFLIXIMAB

NICE Appraisal

TA187  Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn’s disease (review of TA40) (May 2010)

DSU Reports

DSU response to comments on DSU Crohn’s Report 2 (August 2009)

Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease – Report 2 (June 2009)

Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease (January 2009)